When CD4 + T cells obtained from healthy donors were differentiated into Th17 in the presence of various concentrations of tocilizumab and 1,25(OH) 2 D 3 , we observed that the CD4 + IL-17 + population tended to be suppressed by a combination of tocilizumab and 1,25(OH) 2 D 3, although it did not reach statistical significance ( P = 0.063) ( Fig. 1A ).
← all excerpts
1,25-dihydroxy Vitamin D3 and Interleukin-6 Blockade Synergistically Regulate Rheumatoid Arthritis by Suppressing Interleukin-17 Production and Osteoclastogenesis.
1
0.0630
0.0630